Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.

Intraerythrocytic plasmodia form hemozoin as a detoxification product of hemoglobin-derived heme. An identical substance, beta-hematin (BH), can be obtained in vitro from hematin at acidic pH. Quinoline-antimalarials inhibit BH formation. Standardization of test conditions is essential for studying the interaction of compounds with this process and screening potential inhibitors. A spectrophotometric microassay of heme polymerization inhibitory activity (HPIA) (Basilico et al., Journal of Antimicrobial Chemotherapy 42, 55-60, 1998) previously reported was used to investigate the effect of pH and salt concentration on BH formation. The yield of BH formation decreased with pH. Moreover, under conditions used in the above HPIA assay (18 h, 37 degrees C, pH = 2.7), several salts including chloride and phosphate inhibited the process. Aminoquinoline drugs formulated as salts (chloroquine-phosphate, primaquine-diphosphate), but not chloroquine-base, also inhibited the reaction. Interference by salts was highest at low pH and decreased at higher pH (pH 4). Here, we describe different assay conditions that eliminate these problems (BHIA, beta-hematin inhibitory activity). By replacing hematin with hemin as the porphyrin and NaOH solution with DMSO as solvent, the formation of BH was independent of pH up to pH 5.1. No interference by salts was observed over the pH range 2.7-5.1. Dose-dependent inhibition of BH formation was obtained with chloroquine-base, chloroquine-phosphate, and chloroquine-sulfate at pH 5.1. Primaquine was not inhibitory. The final product, characterized by solubility in DMSO, consists of pure BH by FT-IR spectroscopy. The BHIA assay (hemin in DMSO, acetate buffer pH 5 +/- 0.1, 18 h at 37 degrees C) is designed to screen for those molecules forming pi-pi interactions with hematin and thus inhibiting beta-hematin formation.

[1]  J. Vennerstrom,et al.  Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry. , 2000, Biochimica et biophysica acta.

[2]  Peter W. Stephens,et al.  The structure of malaria pigment β-haematin , 2000, Nature.

[3]  G. Blauer,et al.  On the preparation of β-haematin , 2000 .

[4]  D. Wright,et al.  Metalloporphyrins inhibit β-hematin (hemozoin) formation , 2000 .

[5]  Virander S. Chauhan,et al.  Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite* , 1999, The Journal of Biological Chemistry.

[6]  D. Taramelli,et al.  A Novel Endogenous Antimalarial: Fe(II)-Protoporphyrin IXα (Heme) Inhibits Hematin Polymerization to β-Hematin (Malaria Pigment) and Kills Malaria Parasites† , 1999 .

[7]  J. Karle,et al.  Functional correlation of molecular electronic properties with potency of synthetic carbinolamine antimalarial agents. , 1998, Bioorganic & medicinal chemistry.

[8]  D. Taramelli,et al.  A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. , 1998, The Journal of antimicrobial chemotherapy.

[9]  H. Matile,et al.  An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. , 1998, Biochemical pharmacology.

[10]  H. Matile,et al.  A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. , 1998, Biochemical pharmacology.

[11]  T. Egan,et al.  Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. , 1997, Journal of inorganic biochemistry.

[12]  D. Taramelli,et al.  Non‐iron porphyrins inhibit β‐haematin (malaria pigment) polymerisation , 1997 .

[13]  G. Blauer,et al.  Investigations of B- and β-hematin , 1997 .

[14]  R. Dinnebier,et al.  Characterization of the Products of the Heme Detoxification Pathway in Malarial Late Trophozoites by X-ray Diffraction* , 1997, The Journal of Biological Chemistry.

[15]  D. Sullivan,et al.  On the molecular mechanism of chloroquine's antimalarial action. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Egan,et al.  The iron environment in heme and heme-antimalarial complexes of pharmacological interest. , 1996, Journal of inorganic biochemistry.

[17]  D. Goldberg,et al.  The plasmodium digestive vacuole: metabolic headquarters and choice drug target. , 1995, Parasitology today.

[18]  H. Matile,et al.  Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein , 1995, Nature.

[19]  T. Egan,et al.  Quinoline anti‐malarial drugs inhibit spontaneous formation of β‐haematin (malaria pigment) , 1994 .

[20]  D. S. Bohle,et al.  Synthesis of β-hematin by dehydrohalogenation of hemin , 1993 .

[21]  S. Meshnick,et al.  Hemin-catalyzed decomposition of artemisinin (qinghaosu). , 1992, Biochemical pharmacology.

[22]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[23]  I. Constantinidis,et al.  UV-visible and carbon NMR studies of chloroquine binding to urohemin I chloride and uroporphyrin I in aqueous solutions , 1988 .

[24]  J. M. Pratt,et al.  Studies on haemin in dimethyl sulphoxide/water mixtures. , 1979, The Biochemical journal.

[25]  J. W. Buchler.  SYNTHESIS AND PROPERTIES OF METALLOPORPHYRINS , 1979 .

[26]  S. B. Brown,et al.  Aggregation of ferrihaems. Dimerization and protolytic equilibria of protoferrihaem and deuteroferrihaem in aqueous solution. , 1970, The Biochemical journal.

[27]  H. Kobayashi,et al.  Receptors for natriuretic peptides in adrenal chromaffin cells. , 1998, Biochemical pharmacology.

[28]  Kevin M. Smith,et al.  Porphyrins and metalloporphyrins. , 1975 .